Sano et al identified risk factors for significant renal involvement in patients with Henoch-Schonlein purpura. This can help identify patients who may be at risk for developing end-stage renal disease and who may benefit from more aggressive management. The authors are from Saitama Medical Scholl in Kawagoe, Japan.
